Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. - Wikidata - awgldk - TriplyDB

Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome.

Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome.

http://www.wikidata.org/entity/Q35954087

about

Brain-gut axis: from basic understanding to treatment of IBS and related disorders Stress and visceral pain: from animal models to clinical therapies Effects of pregabalin on central sensitization in patients with chronic pancreatitis in a randomized, controlled trial.Bloating in gastroparesis: severity, impact, and associated factors Treatment of irritable bowel syndrome.Different faces of gastroparesis.Review article: new receptor targets for medical therapy in irritable bowel syndrome Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.The treatment of irritable bowel syndrome Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.Avoiding analgesic escalation and excessive healthcare utilization in severe irritable bowel syndrome: a role for intramuscular anticholinergics?The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis.Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome The role of experimental models in developing new treatments for irritable bowel syndrome.Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.Effect of the α2δ ligand, pregabalin, on colonic sensory and motor functions in healthy adults.Evidence-based clinical practice guidelines for irritable bowel syndrome.Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management Visceral pain: the ins and outs, the ups and downs.Pregabalin and placebo responders show different effects on central pain processing in chronic pancreatitis patients.Drug management of visceral pain: concepts from basic research.Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview.The analgesic effect of pregabalin in patients with chronic pain is reflected by changes in pharmaco-EEG spectral indices.alpha2delta ligand: a new, smart pill for visceral pain in patients with hypersensitive irritable bowel syndrome?Psychopharmacological treatment and psychological interventions in irritable bowel syndrome.Pain management in patients with inflammatory bowel disease: insights for the clinician Effects of pregabalin on visceral pain responses and colonic compliance in rats.Recent developments in the therapy of irritable bowel syndrome.Visceral analgesics: drugs with a great potential in functional disorders?Medical management of irritable bowel syndrome in 2008: current and future directions.A review of irritable bowel syndrome and an update on therapeutic approaches.Comparative effects of α2δ-1 ligands in mouse models of colonic hypersensitivity.Management Strategies for Abdominal Bloating and Distension.Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome Current and novel therapeutic options for irritable bowel syndrome management.Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer-based and manual linear interpolation models.Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome.Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.

P2860

Q27024801-75A7CF35-E4EC-4D8E-BC64-7A56A77337CA Q30459512-AFE25504-6606-4B08-8F74-48BD86990259 Q31081451-2A797BC1-E627-4466-9B9F-3E93EFA10F16 Q33450111-958E8334-0AD8-465A-B394-D0AE8688BE2A Q33450370-FC5C22BA-F726-436D-933C-A347C17E802F Q33555343-4A060CFB-A93B-4B4F-B922-BF1A13EA7DD4 Q33959307-423298F6-F1AE-4111-B6E0-B31271EEB4D6 Q34323319-A8D6D943-600E-4D26-959A-21D3BD588581 Q34409009-CDE95FFF-228E-46BD-953F-2ECABC9E62D3 Q34409219-DB9CDB78-82B3-47F4-8CD8-AD3A4D10663A Q34418745-E0CA7426-688C-4FCD-818E-44F0B713AC01 Q34596449-F13C2A2A-842B-46E9-A57C-434EB43885A5 Q34613361-34ECE3A0-47DB-44DE-A17E-FA41969D71C6 Q35018460-51024753-D610-4FDA-8B3D-8A68E1D2FEF1 Q35042476-7D2746CB-FDFD-46D3-8B88-C505EF2AE1E3 Q35071310-A61F63C7-0DD0-4ECE-8B0D-459015873C3B Q35087100-9A8297D1-2B49-4B5D-BF9D-93E1185A175B Q35159654-814756A4-75C2-4A49-9E19-769619919724 Q35513973-43DCF583-0277-459F-A9D3-D4D4799A0517 Q35730465-DD72B35F-D77E-4935-9ABD-297AEA246F59 Q35738047-E9A0261A-A813-460F-9AC5-E34D5CA2BEC5 Q35862174-3059DE9F-D842-45A8-B4BD-C3B11B8223BA Q35947915-CEF3571E-EF15-4EF0-986A-1F5332EC5CBD Q35971357-59E5A669-EF3F-439D-A4A3-74D1B5C2CA36 Q36017364-DD26B8BF-1296-4E43-BADD-E48625EDBF5F Q36023377-0ADCCB75-20EC-4B56-8372-DF3C6CA18B32 Q36203967-B0646A77-164A-4DF8-A21E-068A30FA059C Q36220453-BF1BEF34-4E8C-4205-985B-711716ECB420 Q36938454-E2B7B672-99A8-4E18-B4DF-7BEDE7009CB4 Q37071175-A1431643-0CCB-4A21-84B6-9E8088ADA575 Q37118821-E693F926-088E-4865-A883-AD4DC9ADA887 Q37141316-D81328F9-7A58-432F-8CAF-DE52338B670C Q37142056-4F5FCD49-2845-46F4-BD8B-69B939618AA4 Q37183034-1FB3FFD3-C94C-47C3-99E5-45A93F03C9B5 Q37190545-738E8D98-4136-4283-8F49-2FA8E042E20F Q37228303-FF9DA666-BDC7-46FA-AD8C-68F92108E12D Q37438547-ECBEE8F6-C3C2-4AD7-B525-33C93D59F64F Q37495606-4ABC71AB-8EC2-4CCC-9E47-1A5224EB9F1A Q37624734-D050296A-CF28-4003-8BC0-55715FCF97B6 Q37677017-D213459A-2BC8-4EC0-964F-BE1AD933AD17

P2860

Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome.

http://www.wikidata.org/entity/Q35954087

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Effect of a second-generation ...... with irritable bowel syndrome.

@ast

Effect of a second-generation ...... with irritable bowel syndrome.

@en

type

label

Effect of a second-generation ...... with irritable bowel syndrome.

@ast

Effect of a second-generation ...... with irritable bowel syndrome.

@en

prefLabel

Effect of a second-generation ...... with irritable bowel syndrome.

@ast

Effect of a second-generation ...... with irritable bowel syndrome.

@en

P1433

Q35954087-975D3A06-FB93-4690-87EA-EDDDD7371C2A

P1476

Q35954087-9313445B-EF41-40ED-8A2D-CF58E76DADF6

P2093

Q35954087-0829D4D1-0D72-45CE-A464-668495D1D999

Q35954087-2306E59B-FDC5-47EF-81E4-CE4A47414052

Q35954087-28E0B60B-5B11-4164-9395-FE5F695E528B

Q35954087-3AABCB0F-3F27-4ABF-9BD3-063127B2353B

Q35954087-7733E0E1-6244-467F-B1A0-A2672B8B777A

Q35954087-DB1C764B-BB9C-4DF5-8927-5CB9FF463AA2

P2860

Q35954087-0068F38C-E3F5-4DF5-97A8-C6B0145B5046

Q35954087-1907C12B-2108-4BF0-8767-BC04F6F5BE81

Q35954087-19DF25DC-55E1-4326-85F2-C5A15CC32E1B

Q35954087-1A872358-A83C-48CD-B692-181AA4F283C6

Q35954087-2EEF28EC-C0E8-4386-AA88-44F17094C25C

Q35954087-31A038A3-FE8E-4A9E-A8AA-D230B8278915

Q35954087-3385A134-E089-42B1-9A45-E2E4FE8C8274

Q35954087-371CE668-C7BF-46F6-8E5E-43E132AD7954

Q35954087-40EC267A-648C-46D0-B031-C3CF3C80E9B7

Q35954087-49F87F5B-CD9A-497B-A0D2-AC8A98F62A69

P304

Q35954087-1B445B57-655C-40AB-8FB6-B2134CE1CEB3

P31

Q35954087-0E379F0D-DAAA-42A1-8826-3A2F89DC554D

P356

Q35954087-296E7271-D7BF-4C13-9675-C84C966E6D14

P407

Q35954087-CA56DB5D-FE42-4F3C-A456-B67E9AD801D5

P433

Q35954087-CFCBEC9C-7E8C-4AA3-AD4B-91401497C538

P478

Q35954087-DFA2416C-F071-4743-BA41-1D6BA774FEBB

P577

Q35954087-23A6DA16-36F9-4F46-9E93-3C48637A332D

P5875

Q35954087-8D839489-2DA0-4592-A809-44657B181181

P698

Q35954087-1EE633E1-F6EF-4220-A404-99885FDE8FBC

P932

Q35954087-977A507F-A46C-4B08-8218-052EAF3B1384

P356

GUT.2006.110858

P1433

P1476

Effect of a second-generation ...... with irritable bowel syndrome.

@en

P2093

C Fell

http://www.w3.org/2001/XMLSchema#string

D P Sudworth

http://www.w3.org/2001/XMLSchema#string

I Jones

http://www.w3.org/2001/XMLSchema#string

J D Gale

http://www.w3.org/2001/XMLSchema#string

L A Houghton

http://www.w3.org/2001/XMLSchema#string

P J Whorwell

http://www.w3.org/2001/XMLSchema#string

P2860

Origin of chronic right upper quadrant pain.

Dysmotility of the small intestine in irritable bowel syndrome

The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers

Pregabalin pharmacology and its relevance to clinical practice.

Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception.

Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents.

Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity.

Antinociceptive effect of pregabalin in septic shock-induced rectal hypersensitivity in rats.

The proximal stomach and postprandial symptoms in functional dyspeptics.

P304

1218-1225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2006.110858

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6383118

http://www.w3.org/2001/XMLSchema#string

P698

17446306

http://www.w3.org/2001/XMLSchema#string

P932

1954959

http://www.w3.org/2001/XMLSchema#string